Larry Kaiser, M.D.
President

Susan Coulter, J.D.
Vice President, Office
of Institutional Advancement

Wendy K. Mohon
Editor

Michelle Rexroat
Web Developer I

April, 2006
Table of Contents

Contracts and Grants

 

Information is courtesy of the Office of Sponsored Projects.

New

Ananth Annapragada, School of Health Information Sciences, Nanocarrier-Based CT Contrast Agents for Cardiac Imaging, Marval Therapeutics Inc., $31,999.

Rowen J. Chang, Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, Sponsored Research Agreement with Protein Institute Inc./Protein Conformational Isomers, Protein Institute Inc., $480,000.

Kimberly Napoli Eaton, Medical School (MS), Phase I Trial to Develop Rapamycin as an Antineoplastic Agent, University of Chicago, $14,108.

Craig A. Field, School of Public Health (SPH), Clinical Trials Network: The North Texas Node, UT Southwestern Medical Center at Dallas, $51,040.

Nuria Homedes, SPH, Health Seeking Behavior of Undocumented Immigrants in El Paso County, Paso Del Norte Health Foundation, $56,815.

Ronald Johnson, Administration, Targeted Early Intervention and Retention of Underrepresented Minority Students, Texas Higher Education Coordinating Board, $264,448.

Susan Landry, MS, Texas Early Head Start/Head Start Oral Health Forums, Association of State and Territorial Dental Directors, $2,500.

Robert Levine, MS, A Safety Study to Evaluate Intracranial Pressure with the Utilization of High Frequency Chest Wall Oscillation Using the Vest on Mechanically Ventilated Neurosurgical Patients, Hill-Rom Inc., $58,318.

Maureen D. Mayes, MS, Phase III "In-Life" Study of a Topical Gel Formulation of Nitroglycerin, MQX-503, and Matching Placebo Gel in the Treatment and Prevention of Raynaud’s Phenomenon, Mediquest Therapeutics Inc., $200,000; and Scleroderma: Cyclophosphamide or Transplantation Study, Duke University Medical Center, $239,347.

John Mohr, MS, Clinical Resistance to Caspofungin in a Patient with a Blood Stream Infection Caused by C. Glabrata: Evaluation of Changes in Gene Expression, Astellas Pharma US Inc., $24,106. Barbara E. Murray, MS and Graduate School of Biomedical Sciences (GSBS), Assessment of Activity of Ceftobiprole Against Enterococcus Faecalis in Vitro and in a Mouse Peritonitis Model, Johnson & Johnson, $91,000.

Ponnada A. Narayana, MS and GSBS, 3 T MRI Scanner: Cooperative Studies with Philips, Philips Medical Systems Inc., $200,000; and MRI Prime Award Title: Brain Cell Death Mechanisms after Perinatal, The University of Texas Medical Branch at Galveston, $37,146.

Joe C. Ontiveros, Dental Branch (DB) and GSBS, SEM Evaluation of Crown Preparations Margins Hybridized with Various Dental Adhesives, Reality Publishing Company, $1,600.

Luis Ostrosky-Zeichner, MS, Anti-Candida Antibody Detection Using the Sycan3 Kit on Samples from the NICHD Neonatal Research Network Early Diagnosis of Nosocomial Candidiasis Clinical Trial, Rockeby Biomed Corp. Ltd., $56,000.

Rade Paravina, DB and GSBS, Effect of Accelerated Aging on Color, Translucency and Gloss of Composites, Ultradent Products Inc., $5,000; and Polishing-Dependent Gloss Changes of Composites, Ultradent Products Inc., $5,000

John D. Reveille, MS and GSBS, Highlights from the 2005 ACR Meetings, Amgen Inc., $5,000.

Richard W. Smalling, MS, PATCAR Pilot, Protein Design Labs Inc., $500,000.

Charles T. Van Buren, MS, RNA Impregnated Implants in Mice, Ethicon GMBH & Co. KG, $30,000.

Renewal

Jacqueline T. Hecht, MS and GSBS, Cellular and Molecular Studies of the Exostosis, Shriners Hospital for Crippled Children, $78,137.

Steve Massey, MS and GSBS, Houston Area Vision Training Program, National Institutes of Health (NIH), $926,898.

Dianna M. Milewicz, MS and GSBS, Genetic Basis of Aortic Aneurysms/Dissections, NIH, $1,602,892.

Stephen B. Tucker, MS, The Anti-Tumor Effects of Interferon on Squamous Cell Carcinoma, Clayton Foundation for Research, $60,000.

Jerry S.Wolinsky, MS and GSBS, Viral Mimicry and Multiple Sclerosis, Clayton Foundation for Research, $150,000.